TAMARA BAILEY: Open Payments
NPI 1184122327 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 52 payments from 18 companies in 2025. Trend: 2023 $937 · 2024 $1,038 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $145 |
| Otsuka America Pharmaceutical, Inc. | 8 | $132 |
| Abbott Laboratories | 7 | $116 |
| ABBVIE INC. | 6 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| Axsome Therapeutics, Inc. | 4 | $64 |
| Exact Sciences Corporation | 3 | $53 |
| AtriCure, Inc. | 1 | $40 |
| Lundbeck LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: REXULTI, FREESTYLE LIBRE 3, VRAYLAR, AIRSUPRA, Auvelity, JARDIANCE, BREZTRI, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM.
Industry payments across MO — which companies pay providers there.
